Lupin Jumps After Receiving Clean Chit From FDA
Shares of the drug maker extended gains for the second day and rose as much as 7.1 percent, the most in over five months to Rs 842.80.
The pharmaceutical company received a clean chit from U.S. drug regulator or its Pithampur Unit 1 Facility, according to its stock exchange notification.
Read More: Crude Oil Pares Rally Amid Signals of Expanding American Crude Surplus
The stock declined 9.1 percent so far this year compared to 1.2 percent decline in Sensex.
